Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast Y in post-menopausal women with disease progression following anti-estrogen therapy.
Molecular Weight:
606.8
Purity:
>98%(HPLC)
CAS Number:
[129453-61-8]
Formula:
C32H47F5O3S
Target:
ER
* VAT and and shipping costs not included. Errors and price changes excepted